The MiniMed™ 780G system lets you select your glucose target (5.5, 6.1, or 6.7 mmol/L).
Your browser is out of date
With an updated browser, you will have a better Medtronic web site experience. Update my browser now.
Minimed™ 780G system
MiniMed™ 780G System
Available Now!
For people living with Type 1 diabetes.
Auto
corrections
Auto corrections help make up for carb counts that aren't always exact.*
Personalized
glucose targets
The MiniMed™ 780G system lets you select your glucose target (5.5, 6.1, or 6.7 mmol/L).
Spend more
Time in Range1
Self-adjusts insulin and corrects highs every 5 minutes* to help keep sugars in target range.
More time in automation
Next generation SmartGuard™ technology that takes care of you while you live your life.
SmartGuard™ Technology
The MiniMed™ 780G system with advanced SmartGuard™ tech provides you a more effortless way to stabilize your sugar levels. With new auto correction dosing, the system continuously checks your sugar levels and automatically adjusts insulin delivery and corrects highs to help keep you in range*.
Guardian™ 4 Sensor
No fingersticks with SmartGuard Technology**
Less to do, less to worry about.
Coming 2024 for the MiniMed™ 780G system.†
Read the Press Release on the Health Canada announcement.
Our customers are getting it back with the MiniMed™ 780G system.
"It" is that thing – that one thing that’s uniquely yours. That one thing you love but feel like you don’t get to fully enjoy anymore. Or it’s missing because you’re so focused on your diabetes. Maybe that thing is spending time with loved ones or eating your favorite breakfast food. Our customers are discovering they can get some of these things back with the MiniMed™ 780G system. What will you get back?
Discover your next pump...
find out more today!
No need to complete the form. Check your email inbox for your “Software Update Eligibility Message” or give us a call.
The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more.
*Refers to SmartGuard™ feature. Some user interaction required. Individual results may vary. Data on file. As of November 1, 2022
1. Data on file from CIP 321: Pivotal Trial (Age 14-75). N=152. 2020; 16 US sites